HOME >> BIOLOGY >> NEWS
Cellular espionage at play in post-menopausal osteoporosis

Bone researchers have long known that post-menopausal women are at increased risk of bone loss and diseases such as osteoporosis because of low levels of the hormone estrogen. In recent years, estrogen replacement therapy has been the course of action to prevent bone loss in such women. But not all women are acceptable candidates for this therapy because some may be predisposed to breast, uterine and ovarian cancer risks if they take increased estrogen.

Despite advances in estrogen replacement therapy, it is a source of hot debate in the biomedical community over what cell, molecular and biochemical processes are involved in bone loss associated with declining estrogen levels.

Now a group of biologists at Washington University in St. Louis has shown that lower estrogen levels in post-menopausal women allow a class of inflammatory molecules called cytokines to bind to bone cell surfaces. This in turn gives the green light for specialized cells called osteoclasts to perform their specialty -- bone resorption, or destruction. Moreover, the Washington University team headed by Philip Osdoby, Ph.D., professor of biology in Arts and Sciences, and Teresa Sunyer, Ph.D., research assistant professor of biology, has shown a new relationship between estrogen, bone cell surface receptor proteins and the cytokines Interleukin 1 (IL-1) and Interleukin 8 (IL-8).

Their findings reveal a "cellular espionage" scenario involving signaling receptor proteins and decoy receptor proteins. Osdoby, Sunyer and colleagues found that, in the presence of estrogen, decoy receptor proteins increase in bone cells, preventing cytokines from initiating the path of bone destruction. Without estrogen, signaling receptor proteins flourish and the decoys diminish, letting the osteoclasts erode bone.

The results were published in the May 15, 1999, issue of the Journal of Clinical Investigation. The research was supported by grants from the National Institutes of Health.

B
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
26-Jul-1999


Page: 1 2 3 4

Related biology news :

1. Cellular problems found behind complex obesity syndrome
2. Cellular fat sensor slows heart disease
3. Cellular problem discovered behind syndrome of obesity, learning disabilities
4. Clock cues: Cellular sensing, metabolism research wins Amersham Biosciences and Science Prize
5. Cellular pathway includes a clock that steers gene activity
6. Cellular organelle evolved repeatedly
7. Cellular membrane changes associated with acclimation to cold
8. Dual Control Strategy Assures Accurate Cellular Marching Orders, But A Pathogenic Microbe Can Hijack The System
9. UC Davis Researchers Get First Look At A Working Cellular Motor
10. Cellular Target Of Leprosy, Deadly Viruses Found
11. New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cellular espionage play post menopausal osteoporosis

(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... , Jan. 28, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... the upcoming RedChip Global Online CEO Conference on January ... Gino Pereira , CEO of NXT-ID will ... lead product, the Wocket smart wallet and its full ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the ... report to their offering. , The ... individual is who she/he is claiming to be, and for ... unique physical characteristics, such as fingerprint, hand or palm print, ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
(Date:3/2/2015)... Global Stem Cells Group.com has ... Bioengineering Co., Ltd. and its Chinese-American founder Mingjie ... stem cells training course in the City of ... Shenzhen HANK is a biotechnology company established in ... virologist, to integrate research, development, production, and sales ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine Inc. ... aware of a fraudulent press release disseminated this morning ... be from Immunovaccine. This press release states that Immunovaccine ... Inc. The press release did not originate from ... contained within the press release. Please note that ...
(Date:2/27/2015)... Feb. 27, 2015 Research and Markets ( ... Market Report of Trypsin" report to their offering. ... aims at providing comprehensive data on Trypsin globally and regionally ... North America , Latin America ... attention to Trypsin This report focuses on three ...
(Date:2/27/2015)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology ... announced that it will be presenting at CALBIO 2015 ... nd at 3pm PST. Patrick Lucy, chief business officer ... current state of the biosimilar industry landscape entitled ... For more information on CALBIO 2015 and The ...
Breaking Biology Technology:Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Immunovaccine Disclaims Hoax Press Release 2Global Market Report of Trypsin 2014-2018 2
Cached News: